Literature DB >> 18199924

Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol.

Andrew Coleman1, Stephen Steel, Paul Freeman, Annemarie de Greeff, Andrew Shennan.   

Abstract

BACKGROUND: The Omron M7 (HEM-780-E) is an automated oscillometric upper arm blood pressure monitor for the professional and home use markets. The aim of this study was to validate the accuracy of this device according to the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI) SP10 validation criteria.
METHODS: Participants were recruited until a total of 85 were obtained that filled the blood pressure ranges specified by the BHS protocol. Recruitment to the study was from the general medical and specialist clinics and from the staff at Guy's and St Thomas' Hospital in London, UK. Nine sequential same-arm blood pressure readings were taken from each participant by two trained observers, alternating between a mercury reference sphygmomanometer and the Omron M7 (HEM-780-E). The differences between the reference and test device readings, for both systolic and diastolic pressures, were compared with BHS and AAMI criteria to determine the outcome of the study.
RESULTS: The Omron M7 (HEM-780-E) is graded 'A' for systolic and 'A' for diastolic blood pressures according to the BHS criteria. The mean (standard deviation) of the difference between the observer and the device measurements was 0.75+/-6.5) mmHg for systolic and 1.33+/-5 mmHg for diastolic pressures. The device, therefore, also satisfies the AAMI SP10 standard for the study population, which requires differences of <+/-5 (8) mmHg.
CONCLUSION: The Omron M7 (HEM-780-E) achieved an 'A/A' performance classification under the BHS criteria and passed the AAMI requirements for the study population. It can be recommended for professional and home-use in this population.

Entities:  

Mesh:

Year:  2008        PMID: 18199924     DOI: 10.1097/MBP.0b013e3282cb57b6

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  34 in total

1.  The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities.

Authors:  Lisa A Cooper; Jill A Marsteller; Kathryn A Carson; Katherine B Dietz; Romsai T Boonyasai; Carmen Alvarez; Chidinma A Ibe; Deidra C Crews; Hsin-Chieh Yeh; Edgar R Miller; Cheryl R Dennison-Himmelfarb; Lisa H Lubomski; Tanjala S Purnell; Felicia Hill-Briggs; Nae-Yuh Wang
Journal:  Am Heart J       Date:  2020-05-08       Impact factor: 4.749

2.  Stroke Health and Risk Education (SHARE): design, methods, and theoretical basis.

Authors:  Devin L Brown; Kathleen M Conley; Kenneth Resnicow; Jillian Murphy; Brisa N Sánchez; Joan E Cowdery; Emma Sais; Lynda D Lisabeth; Lesli E Skolarus; Darin B Zahuranec; Geoffrey C Williams; Lewis B Morgenstern
Journal:  Contemp Clin Trials       Date:  2012-03-06       Impact factor: 2.226

3.  Monitoring population sodium intake using spot urine samples: validation in a New Zealand population.

Authors:  R McLean; S Williams; J Mann
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

4.  The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Motohiro Shimizu; Norihiro Furusyo; Yuuki Tanaka; Yoshifumi Kato; Fujiko Mitsumoto-Kaseida; Koji Takayama; Kazuya Ura; Satoshi Hiramine; Takeo Hayashi; Hiroaki Ikezaki; Takeshi Ihara; Haru Mukae; Eiichi Ogawa; Kazuhiro Toyoda; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Int Urol Nephrol       Date:  2016-03-16       Impact factor: 2.370

5.  Short-Term Reproducibility of Masked Hypertension Among Adults Without Office Hypertension.

Authors:  Laura P Cohen; Joseph E Schwartz; Daniel N Pugliese; D Edmund Anstey; Jessica P Christian; Stephanie Jou; Paul Muntner; Daichi Shimbo; Natalie A Bello
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

6.  The Association between Changes in Behavioral Risk Factors for Stroke and Changes in Blood Pressure.

Authors:  Lewis B Morgenstern; Brisa N Sánchez; Kathleen M Conley; Melany C Morgenstern; Emma Sais; Lesli E Skolarus; Deborah A Levine; Devin L Brown
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-21       Impact factor: 2.136

7.  Assessment of a hypertension screening and education intervention in Charlestown, Guyana: Hypertension Evaluation & Learning Program (HELP).

Authors:  Navita Dyal; Lisa Dolovich
Journal:  Can Pharm J (Ott)       Date:  2016-01

8.  Improving BP control through electronic communications: an economic evaluation.

Authors:  Paul A Fishman; Andrea J Cook; Melissa L Anderson; James D Ralston; Sheryl L Catz; David Carrell; James Carlson; Beverly B Green
Journal:  Am J Manag Care       Date:  2013-09       Impact factor: 2.229

9.  Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: The CRONICAS Cohort Study.

Authors:  Maria Lazo-Porras; Antonio Bernabe-Ortiz; Andrea Ruiz-Alejos; Liam Smeeth; Robert H Gilman; William Checkley; German Málaga; J Jaime Miranda
Journal:  Diabetes Res Clin Pract       Date:  2019-08-26       Impact factor: 5.602

10.  Blood pressure checks and diagnosing hypertension (BP-CHECK): Design and methods of a randomized controlled diagnostic study comparing clinic, home, kiosk, and 24-hour ambulatory BP monitoring.

Authors:  Beverly B Green; Melissa L Anderson; Jerry Campbell; Andrea J Cook; Kelly Ehrlich; Sarah Evers; Yoshio N Hall; Clarissa Hsu; Dwayne Joseph; Predrag Klasnja; Karen L Margolis; Jennifer B McClure; Sean A Munson; Mathew J Thompson
Journal:  Contemp Clin Trials       Date:  2019-01-08       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.